Archive for November, 2013


  • RBI report says need to gradually cut gilt invest needs of bks (Cogencis)
  • RBI says Fed stimulus taper may lead to global rate cycle upturn (Cogencis)
  • RBI says will soon issue new bank licences (Cogencis)
  • RBI says PSU banks’ falling capital position a “matter of concern” (Cogencis)
  • India Oct CPI rural labourers inflation 12.48% vs 12.44% Sep (Cogencis)
  • India Oct CPI farm labourers inflation 12.65% vs 12.78% Sep (Cogencis)
  • Fitch says rupee fall not to trigger action on India rating for now (Cogencis)
  • Chidambaram says FY14 fiscal deficit target will not be breached (Cogencis)
  • Oil min slaps around $795 mln more fine on RIL over KG-D6 output (Cogencis)
  • India PM says need to expose PSU cos to more competition (Cogencis)
  • Govt may allow exploration of all hydrocarbons in NELP X blocks (Cogencis)
  • Source says India unlikely to join Euroclear bond settlement system (Cogencis)
  • Source says TRAI proposals on media ownership to be out by Dec end (Cogencis)
  • SC bars all Sahara group companies from selling any property (Cogencis)
  • Food minister says mulling to hike sugar export duty drawback rate (Cogencis)
  • Goldman Sachs economist sees gradual pickup in India’s growth FY14 (Cogencis)
  • Bajaj Auto to begin exporting 200cc petrol-run RE60 quadricycle Feb (Cogencis)
  • Power min awaits oil ministry reply on gas supply to Dabhol plant (Cogencis)
  • Drug regulator says found no irregularity at any Wockhardt unit (Cogencis)
  • Source says Hero MotoCorp launched VRS at Gurgaon, Dharuhera plants (Cogencis)
  • US crude oil stocks rise in wk ended Nov 15; petrol, distillates dn (Cogencis)
  • JSW Steel official says see steel prices stable or rising in 2014 (Cogencis)
  • MD says NCDEX plans to soon launch steel HR coil, new gold futures (Cogencis)
  • Nokia urges HC to allow India asset sale (Cogencis)
  • PetroVietnam offers ONGC Videsh 5 oil, gas block via MoU (Cogencis)
  • Eurozone ministers ‘losing patience’ with Greece (BBC)
  • US Federal Reserve to trim stimulus in coming months (var)
  • UK public finances improve in October as economy grows (var)
  • Sri Lanka aims at over 7.5% growth in next 3 years (TOI)
  • Dollar rises to 4-month high versus yen (var)

Indian pharmaceutical industry is a highly knowledge based industry and is ranked world class in terms of technology, quality, purity, stability and international safety, health and environmental protection in production and supply of bulk drugs. Pharma sector plays a major role in the Indian economy as it caters to around 70% of the country’s total medicines demand including drug intermediates, bulk drugs, tablets and capsules.

Indian pharma sector

Increasing Size of Indian pharma sector

At present, market size of the industry stands at around Rs 1,30,000 crore of which about 50% of revenue is represented by industry’s exports, while the remaining comes from domestic consumption. On global front, Indian pharmaceutical industry stands at 3rd largest in terms of volume and 13th largest in terms of value. With the introduction of product patents system since 2005, industry has now become a worldwide exporter of high quality generic drugs to many countries across the world, including the US, Germany, France, Russia and UK among others.

Export of Pharmaceutical Products

Export of Pharmaceutical Products

Indian pharmaceutical sector is highlyfragmented and unorganized with around 24,000 units with only around 330 large units from organised sector. Industry highly resides on innovations, spend a large portion of their revenue on research and development (R&D) activities.

To read complete Article, get your copy of MAGNUM Connect. To register here visit

Tags: , , ,
Back to top